Table 1.

Demographic and initial oncological data based on the use of targeted therapy

	Targeted therapy group n=60	Absence of targeted therapy group n=39	p
Gender			0.6
Male	43	26
Female	17	13
Age at diagnosis, median (range)	63 (29–101)	66 (20–90)	0.092
Histology type, n (%)			0.11
Clear-cell	50 (83)	29 (74)
Chromophobe	1 (2)	2 (5)
Papillary	3 (5)	1 (3)
Mixed clear-cell/papillary	3 (5)	2 (5)
Undifferentiated	3 (5)	3 (7)
Sarcomatoid	0 (0)	2 (5)
Metastatic burden, n (%)			0.13
Single metastasis	7 (11)	10 (26)
Oligometastasis	22 (37)	9 (23)
Plurimetastasis	31 (52)	20 (51)
Motzer risk stratification scale, n (%)			0.17
Low	13 (22)	8 (20)
Intermediate	34 (57)	11 (28)
High	10 (17)	9 (23)
Unknown	3 (5)	11 (28)